BIO PHARMA NORWAY AS

7069 TRONDHEIM

Finances

Return on Equity

0 %

Current Ratio

19,77

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	1 665 000	1 799 000	1 829 000	1 613 000
Net Income	0	275 000	55 000	84 000
Total Assets	2 073 000	3 486 000	3 296 000	3 096 000
Total Equity	1 972 000	1 973 000	1 973 000	1 918 000

Income (NOK)	2022	2021	2020	2019
Revenue	1 665 000	1 799 000	1 829 000	1 613 000
Expenditure	1 676 000	1 532 000	1 771 000	1 500 000
Operating Profit	−11 000	267 000	58 000	114 000
Financial Income	8 000	8 000	13 000	0
Financial Costs	1 000	0	1 000	6 000
Financial Balance	7 000	8 000	12 000	−6 000
Earnings Before Tax	−4 000	275 000	71 000	108 000
Tax	−4 000	0	16 000	24 000
Net Income	0	275 000	55 000	84 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	77 000	39 000	19 000	23 000
Total Current Assets	1 997 000	3 446 000	3 277 000	3 073 000
Total Assets	2 073 000	3 486 000	3 296 000	3 096 000
Total Retained Equity	401 000	402 000	402 000	402 000
Total Equity	1 972 000	1 973 000	1 973 000	1 918 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	101 000	1 513 000	1 323 000	1 178 000
Total Equity and Debt	2 073 000	3 486 000	3 296 000	3 096 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	1 255 000	1 370 000	1 587 000	1 605 000
Other Income	410 000	429 000	242 000	8 000
Revenue	1 665 000	1 799 000	1 829 000	1 613 000
Cost of Goods Sold	445 000	451 000	591 000	619 000
Salary Costs	55 000	53 000	28 000	34 000
Depreciation	51 000	0	16 000	23 000
Impairment	0	0	0	0
Expenditure	1 676 000	1 532 000	1 771 000	1 500 000
Operating Profit	−11 000	267 000	58 000	114 000
Financial Income	8 000	8 000	13 000	0
Financial Costs	1 000	0	1 000	6 000
Financial Balance	7 000	8 000	12 000	−6 000
Dividends	0	0	0	0
Net Income	0	275 000	55 000	84 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	14 000	14 000	19 000	7 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	51 000	0	0	16 000
Total Tangible Assets	51 000	0	0	16 000
Total Fiancial Fixed Assets	11 000	25 000	0	0
Total Fixed Assets	77 000	39 000	19 000	23 000
Stock	194 000	2 000	105 000	357 000
Total Investments	30 000	0	15 000	0
Cash, Bank	40 000	801 000	479 000	66 000
Total Current Assets	1 997 000	3 446 000	3 277 000	3 073 000
Total Assets	2 073 000	3 486 000	3 296 000	3 096 000
Total Equity	1 972 000	1 973 000	1 973 000	1 918 000
Short-Term Group Debt	0	0	0	1 098 000
Total Long-Term Debt	0	0	0	0
Creditors	108 000	79 000	159 000	76 000
Unpaid Taxes	−7 000	15 000	12 000	4 000
Dividends	0	0	0	0
Other Current Debt	0	1 419 000	1 137 000	0
Total Current Debt	101 000	1 513 000	1 323 000	1 178 000
Total Equity and Debt	2 073 000	3 486 000	3 296 000	3 096 000

Financial indicators	2022	2021	2020	2019
Return on Equity	0 %	13,94 %	2,79 %	4,38 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	−0,66 %	14,84 %	3,17 %	7,07 %
Current Ratio	19,77	2,28	2,48	2,61
Quick Ratio	−21,47	2,28	2,69	3,74
Equity Ratio	0,95	0,57	0,6	0,62
Gross Profit Margin	73,27 %	74,93 %	67,69 %	61,62 %